← FDA Drug Approvals (Drugs@FDA)

FEBUXOSTAT

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: AUROBINDO PHARMA LTD · Approved 2023-10-25

Drug application

FDA Application #

ANDA210741

Application type

Abbreviated New Drug Application (Generic)

Brand name

FEBUXOSTAT

Generic name

FEBUXOSTAT

Active ingredients

FEBUXOSTAT

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

AUROBINDO PHARMA LTD

Manufacturer

Aurobindo Pharma Limited

First approval

2023-10-25

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown